252 related articles for article (PubMed ID: 7912626)
1. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
Kennett GA; Wood MD; Glen A; Grewal S; Forbes I; Gadre A; Blackburn TP
Br J Pharmacol; 1994 Mar; 111(3):797-802. PubMed ID: 7912626
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.
Kennett GA; Wood MD; Bright F; Cilia J; Piper DC; Gager T; Thomas D; Baxter GS; Forbes IT; Ham P; Blackburn TP
Br J Pharmacol; 1996 Feb; 117(3):427-434. PubMed ID: 8821530
[TBL] [Abstract][Full Text] [Related]
3. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
Kennett GA; Wood MD; Bright F; Trail B; Riley G; Holland V; Avenell KY; Stean T; Upton N; Bromidge S; Forbes IT; Brown AM; Middlemiss DN; Blackburn TP
Neuropharmacology; 1997; 36(4-5):609-20. PubMed ID: 9225286
[TBL] [Abstract][Full Text] [Related]
4. Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat.
Duxon MS; Kennett GA; Lightowler S; Blackburn TP; Fone KC
Neuropharmacology; 1997; 36(4-5):601-8. PubMed ID: 9225285
[TBL] [Abstract][Full Text] [Related]
5. Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.
Kennett GA; Bailey F; Piper DC; Blackburn TP
Psychopharmacology (Berl); 1995 Mar; 118(2):178-82. PubMed ID: 7617805
[TBL] [Abstract][Full Text] [Related]
6. Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety.
Kennett GA; Bright F; Trail B; Baxter GS; Blackburn TP
Br J Pharmacol; 1996 Apr; 117(7):1443-8. PubMed ID: 8730737
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
Kennett GA; Trail B; Bright F
Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
Millan MJ; Peglion JL; Lavielle G; Perrin-Monneyron S
Eur J Pharmacol; 1997 Apr; 325(1):9-12. PubMed ID: 9151932
[TBL] [Abstract][Full Text] [Related]
9. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
Blackburn TP; Suzuki K; Ashby CR
Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
[TBL] [Abstract][Full Text] [Related]
10. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.
Hemrick-Luecke SK; Fuller RW
Eur J Pharmacol; 1996 Sep; 311(2-3):207-11. PubMed ID: 8891601
[TBL] [Abstract][Full Text] [Related]
12. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
13. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
[TBL] [Abstract][Full Text] [Related]
14. SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.
Wood MD; Reavill C; Trail B; Wilson A; Stean T; Kennett GA; Lightowler S; Blackburn TP; Thomas D; Gager TL; Riley G; Holland V; Bromidge SM; Forbes IT; Middlemiss DN
Neuropharmacology; 2001 Aug; 41(2):186-99. PubMed ID: 11489455
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice.
Nic Dhonnchadha BA; Hascoët M; Jolliet P; Bourin M
Behav Brain Res; 2003 Dec; 147(1-2):175-84. PubMed ID: 14659583
[TBL] [Abstract][Full Text] [Related]
16. Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.
Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
Eur J Pharmacol; 1996 Jun; 307(1):75-80. PubMed ID: 8831107
[TBL] [Abstract][Full Text] [Related]
17. The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds.
Prinssen EP; Koek W; Kleven MS
Eur J Pharmacol; 2000 Jan; 388(1):57-67. PubMed ID: 10657547
[TBL] [Abstract][Full Text] [Related]
18. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
[TBL] [Abstract][Full Text] [Related]
19. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
[TBL] [Abstract][Full Text] [Related]
20. Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.
Upton N; Stean T; Middlemiss D; Blackburn T; Kennett G
Eur J Pharmacol; 1998 Oct; 359(1):33-40. PubMed ID: 9831290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
